397192001: Fluticasone (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\...

\Glucocorticoid (substance)\Fluticasone (substance)

\Fluorinated corticosteroid\Fluticasone (substance)

\Drug or medicament (substance)\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Fluticasone (substance)
\Drug or medicament (substance)\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Fluticasone (substance)
\Drug or medicament (substance)\Hormone\Steroid hormone\Glucocorticoid (substance)\Fluticasone (substance)
\Drug or medicament (substance)\Hormone\Steroid hormone\Fluorinated corticosteroid\Fluticasone (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Organic cyclic compound\Polycyclic compound\Steroid (substance)\...

\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Fluticasone (substance)
\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Fluticasone (substance)

\Androstane\Fluticasone (substance)

\Steroid hormone\Glucocorticoid (substance)\Fluticasone (substance)
\Steroid hormone\Fluorinated corticosteroid\Fluticasone (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fluticasone (substance)	Is a	Anti-inflammatory agent	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone (substance)	Is a	corticostéroïde pour administration pulmonaire	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone (substance)	Has disposition	Androgen receptor agonist (disposition)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone (substance)	Has disposition	Gonadal hormone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone (substance)	Is a	Androstane	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone (substance)	Is a	Fluorinated corticosteroid	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone (substance)	Is a	Glucocorticoid (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone (substance)	Has disposition	Hormone (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fluticasone propionate	Is a	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing fluticasone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing fluticasone in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone adverse reaction	Causative agent (attribute)	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Allergy to fluticasone (finding)	Causative agent (attribute)	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone- and salmeterol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 250mcg/50mcg powder for oral inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 500mcg/50mcg powder for oral inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone furoate (substance)	Is a	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing fluticasone in nasal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone- and salmeterol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Allergy to fluticasone (finding)	Causative agent (attribute)	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone- and vilanterol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing fluticasone and vilanterol in respiratory dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing fluticasone and umeclidinium and vilanterol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing fluticasone and umeclidinium and vilanterol in respiratory dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone furoate (substance)	Is modification of (attribute)	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Is modification of (attribute)	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing fluticasone in pulmonary dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone- and umeclidinium- and vilanterol-containing product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone- and vilanterol-containing product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing fluticasone in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing fluticasone and salmeterol in pulmonary dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only fluticasone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only fluticasone and salmeterol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing only fluticasone and umeclidinium and vilanterol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone and vilanterol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone and salmeterol only product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluticasone and vilanterol only product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone only product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone only product in nasal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing only fluticasone in pulmonary dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone and umeclidinium and vilanterol only product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing azelastine and fluticasone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Azelastine and fluticasone only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Azelastine and fluticasone only product in nasal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Azelastine- and fluticasone-containing product in nasal dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluticasone and formoterol only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone- and formoterol-containing product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing fluticasone and formoterol (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone and formoterol only product in pulmonary dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Fluticasone (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1765110017	Fluticasone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1776880018	Fluticasone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1765110017	Fluticasone (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1765110017	Fluticasone (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1776880018	Fluticasone	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1776880018	Fluticasone	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
54571000195115	fluticasone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
68941000195116	Fluticason	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
812921000172115	fluticasone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
812921000172115	fluticasone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
54571000195115	fluticasone	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
68941000195116	Fluticason	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module